 | • レポートコード：GIR-2104Z10724 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペプチドの種類別市場規模（インスリン、テリパラチド、リラグルチド、リュープロリド）、用途別市場規模（糖尿病、感染症、がん、骨粗鬆症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Cipla Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Gland Pharma Limited、Troikaa Pharmaceuticals Ltd.、Biological E Limited、Bharat Biotech、Samarth Life Sciences Pvt. Ltd.、VHB Life Sciences Limited、Celon Laboratories Pvt. Ltd.、United Biotech (P) Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インスリン、テリパラチド、リラグルチド、リュープロリド ・用途別分析2016年-2026年：糖尿病、感染症、がん、骨粗鬆症 ・ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Peptides size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Peptides market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Peptides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin
Teriparatide
Liraglutide
Leuprolide
Market segment by Application can be divided into
Diabetes
Infectious Diseases
Cancer
Osteoporosis
The key market players for global Peptides market are listed below:
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech (P) Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptides Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptides Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Global Peptides Market Size & Forecast
1.4.1 Global Peptides Sales in Value (2016-2026))
1.4.2 Global Peptides Sales in Volume (2016-2026)
1.4.3 Global Peptides Price by Type (2016-2026) & (USD/MT)
1.5 Global Peptides Production Capacity Analysis
1.5.1 Global Peptides Total Production Capacity (2016-2026)
1.5.2 Global Peptides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peptides Market Drivers
1.6.2 Peptides Market Restraints
1.6.3 Peptides Trends Analysis
2 Manufacturers Profiles
2.1 Cipla Ltd.
2.1.1 Cipla Ltd. Details
2.1.2 Cipla Ltd. Major Business
2.1.3 Cipla Ltd. Peptides Product and Services
2.1.4 Cipla Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Emcure Pharmaceuticals Pvt. Ltd.
2.2.1 Emcure Pharmaceuticals Pvt. Ltd. Details
2.2.2 Emcure Pharmaceuticals Pvt. Ltd. Major Business
2.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Product and Services
2.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Gland Pharma Limited
2.3.1 Gland Pharma Limited Details
2.3.2 Gland Pharma Limited Major Business
2.3.3 Gland Pharma Limited Peptides Product and Services
2.3.4 Gland Pharma Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Troikaa Pharmaceuticals Ltd.
2.4.1 Troikaa Pharmaceuticals Ltd. Details
2.4.2 Troikaa Pharmaceuticals Ltd. Major Business
2.4.3 Troikaa Pharmaceuticals Ltd. Peptides Product and Services
2.4.4 Troikaa Pharmaceuticals Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Biological E Limited
2.5.1 Biological E Limited Details
2.5.2 Biological E Limited Major Business
2.5.3 Biological E Limited Peptides Product and Services
2.5.4 Biological E Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Peptides Product and Services
2.6.4 Bharat Biotech Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Samarth Life Sciences Pvt. Ltd.
2.7.1 Samarth Life Sciences Pvt. Ltd. Details
2.7.2 Samarth Life Sciences Pvt. Ltd. Major Business
2.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Product and Services
2.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 VHB Life Sciences Limited
2.8.1 VHB Life Sciences Limited Details
2.8.2 VHB Life Sciences Limited Major Business
2.8.3 VHB Life Sciences Limited Peptides Product and Services
2.8.4 VHB Life Sciences Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Celon Laboratories Pvt. Ltd.
2.9.1 Celon Laboratories Pvt. Ltd. Details
2.9.2 Celon Laboratories Pvt. Ltd. Major Business
2.9.3 Celon Laboratories Pvt. Ltd. Peptides Product and Services
2.9.4 Celon Laboratories Pvt. Ltd. Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 United Biotech (P) Limited
2.10.1 United Biotech (P) Limited Details
2.10.2 United Biotech (P) Limited Major Business
2.10.3 United Biotech (P) Limited Peptides Product and Services
2.10.4 United Biotech (P) Limited Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Peptides Sales by Manufacturer
3.1 Global Peptides Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Peptides Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Peptides
3.4 Market Concentration Rate
3.4.1 Top 3 Peptides Manufacturer Market Share
3.4.2 Top 6 Peptides Manufacturer Market Share
3.5 Global Peptides Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Peptides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peptides Market Size by Region
4.1.1 Global Peptides Sales in Volume by Region (2016-2026)
4.1.2 Global Peptides Revenue by Region (2016-2026)
4.2 North America Peptides Revenue (2016-2026)
4.3 Europe Peptides Revenue (2016-2026)
4.4 Asia-Pacific Peptides Revenue (2016-2026)
4.5 South America Peptides Revenue (2016-2026)
4.6 Middle East and Africa Peptides Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Peptides Sales in Volume by Type (2016-2026)
5.2 Global Peptides Revenue by Type (2016-2026)
5.3 Global Peptides Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Peptides Sales in Volume by Application (2016-2026)
6.2 Global Peptides Revenue by Application (2016-2026)
6.3 Global Peptides Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Peptides Sales by Type (2016-2026)
7.2 North America Peptides Sales by Application (2016-2026)
7.3 North America Peptides Market Size by Country
7.3.1 North America Peptides Sales in Volume by Country (2016-2026)
7.3.2 North America Peptides Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Peptides Sales by Type (2016-2026)
8.2 Europe Peptides Sales by Application (2016-2026)
8.3 Europe Peptides Market Size by Country
8.3.1 Europe Peptides Sales in Volume by Country (2016-2026)
8.3.2 Europe Peptides Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Peptides Sales by Type (2016-2026)
9.2 Asia-Pacific Peptides Sales by Application (2016-2026)
9.3 Asia-Pacific Peptides Market Size by Region
9.3.1 Asia-Pacific Peptides Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Peptides Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Peptides Sales by Type (2016-2026)
10.2 South America Peptides Sales by Application (2016-2026)
10.3 South America Peptides Market Size by Country
10.3.1 South America Peptides Sales in Volume by Country (2016-2026)
10.3.2 South America Peptides Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peptides Sales by Type (2016-2026)
11.2 Middle East & Africa Peptides Sales by Application (2016-2026)
11.3 Middle East & Africa Peptides Market Size by Country
11.3.1 Middle East & Africa Peptides Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Peptides Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Peptides Typical Distributors
12.3 Peptides Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Peptides Revenue by Type, (USD Million), 2021-2026
Table 2. Global Peptides Revenue by Application, (USD Million), 2021-2026
Table 3. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Cipla Ltd. Major Business
Table 5. Cipla Ltd. Peptides Product and Services
Table 6. Cipla Ltd. Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Emcure Pharmaceuticals Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Emcure Pharmaceuticals Pvt. Ltd. Major Business
Table 9. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product and Services
Table 10. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 12. Gland Pharma Limited Major Business
Table 13. Gland Pharma Limited Peptides Product and Services
Table 14. Gland Pharma Limited Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Troikaa Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Troikaa Pharmaceuticals Ltd. Major Business
Table 17. Troikaa Pharmaceuticals Ltd. Peptides Product and Services
Table 18. Troikaa Pharmaceuticals Ltd. Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 20. Biological E Limited Major Business
Table 21. Biological E Limited Peptides Product and Services
Table 22. Biological E Limited Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Bharat Biotech Major Business
Table 25. Bharat Biotech Peptides Product and Services
Table 26. Bharat Biotech Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Samarth Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Samarth Life Sciences Pvt. Ltd. Major Business
Table 29. Samarth Life Sciences Pvt. Ltd. Peptides Product and Services
Table 30. Samarth Life Sciences Pvt. Ltd. Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. VHB Life Sciences Limited Basic Information, Manufacturing Base and Competitors
Table 32. VHB Life Sciences Limited Major Business
Table 33. VHB Life Sciences Limited Peptides Product and Services
Table 34. VHB Life Sciences Limited Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Celon Laboratories Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Celon Laboratories Pvt. Ltd. Major Business
Table 37. Celon Laboratories Pvt. Ltd. Peptides Product and Services
Table 38. Celon Laboratories Pvt. Ltd. Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. United Biotech (P) Limited Basic Information, Manufacturing Base and Competitors
Table 40. United Biotech (P) Limited Major Business
Table 41. United Biotech (P) Limited Peptides Product and Services
Table 42. United Biotech (P) Limited Peptides Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Peptides Sales by Manufacturer (2019-2021e) & (K MT)
Table 44. Global Peptides Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Peptides Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Peptides Production Site of Key Manufacturer
Table 48. Global Peptides Sales by Region (2016-2021e) & (K MT)
Table 49. Global Peptides Sales by Region (2021-2026) & (K MT)
Table 50. Global Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Peptides Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Peptides Sales by Type (2016-2021e) & (K MT)
Table 53. Global Peptides Sales by Type (2021-2026) & (K MT)
Table 54. Global Peptides Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Peptides Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Peptides Price by Type (2016-2021e) & (USD/MT)
Table 57. Global Peptides Price by Type (2021-2026) & (USD/MT)
Table 58. Global Peptides Sales by Application (2016-2021e) & (K MT)
Table 59. Global Peptides Sales by Application (2021-2026) & (K MT)
Table 60. Global Peptides Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Peptides Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Peptides Price by Application (2016-2021e) & (USD/MT)
Table 63. Global Peptides Price by Application (2021-2026) & (USD/MT)
Table 64. North America Peptides Sales by Country (2016-2021e) & (K MT)
Table 65. North America Peptides Sales by Country (2021-2026) & (K MT)
Table 66. North America Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Peptides Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Peptides Sales by Type (2016-2021e) & (K MT)
Table 69. North America Peptides Sales by Type (2021-2026) & (K MT)
Table 70. North America Peptides Sales by Application (2016-2021e) & (K MT)
Table 71. North America Peptides Sales by Application (2021-2026) & (K MT)
Table 72. Europe Peptides Sales by Country (2016-2021e) & (K MT)
Table 73. Europe Peptides Sales by Country (2021-2026) & (K MT)
Table 74. Europe Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Peptides Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Peptides Sales by Type (2016-2021e) & (K MT)
Table 77. Europe Peptides Sales by Type (2021-2026) & (K MT)
Table 78. Europe Peptides Sales by Application (2016-2021e) & (K MT)
Table 79. Europe Peptides Sales by Application (2021-2026) & (K MT)
Table 80. Asia-Pacific Peptides Sales by Region (2016-2021e) & (K MT)
Table 81. Asia-Pacific Peptides Sales by Region (2021-2026) & (K MT)
Table 82. Asia-Pacific Peptides Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Peptides Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Peptides Sales by Type (2016-2021e) & (K MT)
Table 85. Asia-Pacific Peptides Sales by Type (2021-2026) & (K MT)
Table 86. Asia-Pacific Peptides Sales by Application (2016-2021e) & (K MT)
Table 87. Asia-Pacific Peptides Sales by Application (2021-2026) & (K MT)
Table 88. South America Peptides Sales by Country (2016-2021e) & (K MT)
Table 89. South America Peptides Sales by Country (2021-2026) & (K MT)
Table 90. South America Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Peptides Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Peptides Sales by Type (2016-2021e) & (K MT)
Table 93. South America Peptides Sales by Type (2021-2026) & (K MT)
Table 94. South America Peptides Sales by Application (2016-2021e) & (K MT)
Table 95. South America Peptides Sales by Application (2021-2026) & (K MT)
Table 96. Middle East & Africa Peptides Sales by Country (2016-2021e) & (K MT)
Table 97. Middle East & Africa Peptides Sales by Country (2021-2026) & (K MT)
Table 98. Middle East & Africa Peptides Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Peptides Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Peptides Sales by Type (2016-2021e) & (K MT)
Table 101. Middle East & Africa Peptides Sales by Type (2021-2026) & (K MT)
Table 102. Middle East & Africa Peptides Sales by Application (2016-2021e) & (K MT)
Table 103. Middle East & Africa Peptides Sales by Application (2021-2026) & (K MT)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Peptides Typical Distributors
Table 107. Peptides Typical Customers
List of Figures
Figure 1. Peptides Picture
Figure 2. Global Peptides Sales Market Share by Type in 2020
Figure 3. Insulin
Figure 4. Teriparatide
Figure 5. Liraglutide
Figure 6. Leuprolide
Figure 7. Global Peptides Sales Market Share by Application in 2020
Figure 8. Diabetes
Figure 9. Infectious Diseases
Figure 10. Cancer
Figure 11. Osteoporosis
Figure 12. Global Peptides Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Peptides Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Peptides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Peptides Sales (2016-2026) & (K MT)
Figure 34. Global Peptides Production Capacity (2016-2026) & (K MT)
Figure 35. Global Peptides Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Peptides Market Drivers
Figure 37. Peptides Market Restraints
Figure 38. Peptides Market Trends
Figure 39. Global Peptides Sales Market Share by Manufacturer in 2020
Figure 40. Global Peptides Revenue Market Share by Manufacturer in 2020
Figure 41. Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Peptides Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Peptides Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Peptides Sales Market Share by Region (2016-2026)
Figure 45. Global Peptides Revenue Market Share by Region (2016-2026)
Figure 46. North America Peptides Revenue (2016-2026) & (USD Million)
Figure 47. Europe Peptides Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Peptides Revenue (2016-2026) & (USD Million)
Figure 49. South America Peptides Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Peptides Revenue (2016-2026) & (USD Million)
Figure 51. Global Peptides Sales Market Share by Type (2016-2026)
Figure 52. Global Peptides Revenue Market Share by Type (2016-2026)
Figure 53. Global Peptides Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Peptides Sales Market Share by Application (2016-2026)
Figure 55. Global Peptides Revenue Market Share by Application (2016-2026)
Figure 56. Global Peptides Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Peptides Sales Market Share by Country (2016-2026)
Figure 58. North America Peptides Revenue Market Share by Country (2016-2026)
Figure 59. North America Peptides Sales Market Share by Type (2016-2026)
Figure 60. North America Peptides Sales Market Share by Application (2016-2026)
Figure 61. Europe Peptides Sales Market Share by Country (2016-2026)
Figure 62. Europe Peptides Revenue Market Share by Country (2016-2026)
Figure 63. Europe Peptides Sales Market Share by Type (2016-2026)
Figure 64. Europe Peptides Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Peptides Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Peptides Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Peptides Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Peptides Sales Market Share by Application (2016-2026)
Figure 69. South America Peptides Sales Market Share by Country (2016-2026)
Figure 70. South America Peptides Revenue Market Share by Country (2016-2026)
Figure 71. South America Peptides Sales Market Share by Type (2016-2026)
Figure 72. South America Peptides Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Peptides Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Peptides Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Peptides Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Peptides Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のペプチド・ヘパリン市場 2021：企業別、地域別、種類・用途別 The Peptides and Heparin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界のペプチドバイオシミラー市場規模・現状・予測（2021年-2027年） Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. The statistic scope in this report is peptides biosimilars. Market Analysis and Insights: Global Peptides Biosimilars Market The global Peptides Biosimilars market size is projected to reach US$ XX million by 2026, fro…
- 世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年） Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. Market Analysis and Insights: Global Endocrine Peptides Test Market The global Endocrine Peptides Test market size is projected to reach …
- 世界の内分泌ペプチド検査市場規模・現状・予測（2021年-2027年） Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. Market Analysis and Insights: Global Endocrine Peptides Test Market The global Endocrine Peptides Test market size is projected to reach …
- 世界の合成ペプチド市場 2021：企業別、地域別、種類・用途別 The Synthetic Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…